Oncolytic virus therapy is a promising new option for cancer. It utilizes genetically
engineered or naturally occurring viruses that selectively replicate in and kill cancer cells …

Oncolytic virus therapy is perhaps the next major breakthrough in cancer treatment following
the success in immunotherapy using immune checkpoint inhibitors. Oncolytic viruses are …

Oncolytic viruses (OVs) are an emerging class of cancer therapeutics that offer the benefits
of selective replication in tumour cells, delivery of multiple eukaryotic transgene payloads …

Oncolytic viruses (OVs) are viral strains that can infect and kill malignant cells while spare
their normal counterparts. OVs can access cells through binding to receptors on their surface …

Oncolytic viral therapy has been accepted as a standard immunotherapy since talimogene
laherparepvec (T-VEC, Imlygic®) was approved by the Food and Drug Administration (FDA) …

This review discusses current clinical advancements in oncolytic viral therapy, with a focus
on the viral platforms approved for clinical use and highlights the benefits each platform …

In view of the advancement in the understanding about the most diverse types of cancer and
consequently a relentless search for a cure and increased survival rates of cancer patients …

Administration of oncolytic viruses (OVs) is an emerging anticancer strategy that exploits the
lytic nature of viral replication to enhance the killing of malignant cells. OVs can be used as …

Importance Oncolytic viruses (OVs) are emerging as important agents in cancer treatment.
Oncolytic viruses offer the attractive therapeutic combination of tumor-specific cell lysis …

Viruses as cancer therapies have attracted attention since the 19th century. Scientists
observation that viruses can preferentially lyse cancer cells rather than healthy cells, created …